Cargando…

Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors

Breast cancer (BC) is the most frequent oncologic cause of death among women and the improvement of its treatments is compelling. Platinum salts (e.g., carboplatin, cisplatin, and oxaliplatin) are old drugs still used to treat BC, especially the triple-negative subgroup. However, only a subset of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garutti, Mattia, Pelizzari, Giacomo, Bartoletti, Michele, Malfatti, Matilde Clarissa, Gerratana, Lorenzo, Tell, Gianluca, Puglisi, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678596/ https://www.ncbi.nlm.nih.gov/pubmed/31295913 http://dx.doi.org/10.3390/ijms20143390

Ejemplares similares

APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC
por: Malfatti, Matilde Clarissa, et al.
Publicado: (2019)

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis
por: Bartoletti, Michele, et al.
Publicado: (2020)

Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons
por: Malfatti, Matilde Clarissa, et al.
Publicado: (2023)

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker
por: Pelizzari, Giacomo, et al.
Publicado: (2019)

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside
por: Basile, Debora, et al.
Publicado: (2019)

Liquid Biopsy, an Everchanging Balance between Clinical Utility and Emerging Technologies
por: Cucciniello, Linda, et al.
Publicado: (2022)

“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers
por: Garutti, Mattia, et al.
Publicado: (2020)

Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis
por: Gerratana, Lorenzo, et al.
Publicado: (2020)

Role of condensates in modulating DNA repair pathways and its implication for chemoresistance
por: Dall’Agnese, Giuseppe, et al.
Publicado: (2023)

Enzymatically active apurinic/apyrimidinic endodeoxyribonuclease 1 is released by mammalian cells through exosomes
por: Mangiapane, Giovanna, et al.
Publicado: (2021)

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study
por: Basile, Debora, et al.
Publicado: (2021)

The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
por: Basile, Debora, et al.
Publicado: (2019)

Abasic and oxidized ribonucleotides embedded in DNA are processed by human APE1 and not by RNase H2
por: Malfatti, Matilde Clarissa, et al.
Publicado: (2017)

Seven Shades of Black Thoughts: COVID-19 and Its Psychological Consequences on Cancer Patients
por: Garutti, Mattia, et al.
Publicado: (2020)

Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients
por: Da Col, Giacomo, et al.
Publicado: (2022)

An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer
por: Bartoletti, Michele, et al.
Publicado: (2022)

Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN
por: Codrich, Marta, et al.
Publicado: (2021)

Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
por: Garufi, Giovanna, et al.
Publicado: (2023)

Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma
por: Garutti, Mattia, et al.
Publicado: (2021)

An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer
por: Roncato, Rossana, et al.
Publicado: (2022)

Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
por: Bartoletti, Michele, et al.
Publicado: (2022)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
por: Pelizzari, Giacomo, et al.
Publicado: (2018)

Toxicity of platinum (IV) salts for cells of pulmonary origin.
por: Waters, M D, et al.
Publicado: (1975)

One-dimensional Magnus-type platinum double salts
por: Hendon, Christopher H., et al.
Publicado: (2016)

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example
por: Gerratana, Lorenzo, et al.
Publicado: (2016)

Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer
por: D’Amico, Paolo, et al.
Publicado: (2021)

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
por: Bulfoni, Michela, et al.
Publicado: (2016)

CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
por: Garutti, Mattia, et al.
Publicado: (2021)

BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis
por: Garutti, Mattia, et al.
Publicado: (2022)

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
por: Garutti, Mattia, et al.
Publicado: (2022)

Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives
por: Dall’Acqua, Alessandra, et al.
Publicado: (2021)

Studies on the evaluation of the toxicity of various salts of lead, manganese, platinum, and palladium.
por: Holbrook, D J, et al.
Publicado: (1975)

Effect of platinum and palladium salts on thymidine incorporation into DNA of rat tissues.
por: Fisher, R F, et al.
Publicado: (1975)

Platinum-group elements and gold in silver coinage and the issue of salt cementation
por: Albarède, Francis, et al.
Publicado: (2023)

Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool
por: Garutti, Mattia, et al.
Publicado: (2023)

Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients
por: Zhang, Shiheng, et al.
Publicado: (2016)

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers
por: Birkbak, N J, et al.
Publicado: (2018)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2020)

Methanol Steam Reforming Promoted by Molten Salt-Modified Platinum on Alumina Catalysts
por: Kusche, Matthias, et al.
Publicado: (2014)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lqkjrfug4g5bbsn0lttr3bl3aj